Standout Papers
Immediate Impact
2 by Nobel laureates 23 from Science/Nature 61 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Transferrin receptor targeting chimeras for membrane protein degradation
2024 StandoutNature
Works of Paul Smith being referenced
Rituximab versus a watch-and-wait approach in patients with advanced-stage, asymptomatic, non-bulky follicular lymphoma: an open-label randomised phase 3 trial
2014
Myocardial Infarction Mortality Risk After Treatment for Hodgkin Disease: A Collaborative British Cohort Study
2007
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul Smith | 1884 | 1370 | 423 | 767 | 66 | 3.4k | |
| Hans–Konrad Müller–Hermelink | 2034 | 1291 | 585 | 742 | 64 | 3.8k | |
| Wendi Qian | 1916 | 2203 | 553 | 744 | 81 | 4.2k | |
| Mars B. vanʼt Veer | 1658 | 1022 | 390 | 795 | 58 | 3.7k | |
| Alessandro Levis | 2101 | 1271 | 600 | 745 | 98 | 3.8k | |
| Brian Skinnider | 2290 | 1682 | 630 | 789 | 70 | 3.7k | |
| Franca Fossati‐Bellani | 1138 | 1170 | 692 | 1393 | 82 | 4.2k | |
| Bouthaina S. Dabaja | 1484 | 1157 | 343 | 804 | 141 | 3.0k | |
| E.M. Noordijk | 1845 | 1292 | 416 | 692 | 50 | 2.7k | |
| Lars Møller Pedersen | 2076 | 1368 | 944 | 569 | 103 | 3.3k | |
| Emilio Iannitto | 2349 | 1255 | 895 | 630 | 77 | 3.4k |
All Works
Loading papers...